Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 22,216
-639 (-2.80%)
Aug 10, 2026, 3:30 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 284.74 billion as of August 10, 2026. Its market cap has increased by 69.29% in one year.
Market Cap
284.74B
Enterprise Value
286.99B
Revenue
23.72B
Ranking
n/a
PE Ratio
57.20
Stock Price
22,216.00
ChartMarket Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 284.74B, an increase of 84,862.43%. That is a compound annual growth rate of 30.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 284.74B | 46.10% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 440.38B |
| Ajanta Pharma | 435.76B |
| Gland Pharma | 428.53B |
| Emcure Pharmaceuticals | 375.08B |
| Wockhardt | 328.40B |
| Piramal Pharma | 278.11B |
| Eris Lifesciences | 191.56B |
| Cohance Lifesciences | 170.53B |